Installed Building Products has spent two decades consolidating fragmented residential insulation installers into a roughly three billion revenue platform, and it has now begun pointing that same playbook at commercial mechanical insulation, glass and drywall, and manufacturing distribution. The strategic logic is sound and the execution has been visible in the numbers: commercial same-branch sales grew more than 10 percent in the most recent quarter while residential installations continued to erode under housing affordability pressure. The question for shareholders is whether the mix shift is durable enough to carry the balance sheet, because the growth has been funded with debt, including a $500 million senior notes offering closed in late 2025. The company has run this rollup through three housing cycles without a financing event, and the current structure is the latest chapter of that pattern.
The financial profile is genuinely strong by cyclical standards. Fiscal 2025 delivered record adjusted EBITDA of $518.5 million on a top line near three billion. The EBITDA margin reached 17.5 percent. Operating cash flow came in at $371 million, and free cash flow ran near $300 million. The company repurchased roughly 850,000 shares for $172.6 million in the year and raised both its regular and variable dividends. Against that, Fitch assigned a first-time long-term issuer default rating of BB+ with a stable outlook, two notches below investment grade, a label that prices real leverage and real cyclicality into the cost of capital. The cash flow strength is real, and the credit label is the price of the debt that built it.
The near-term read on 2026 has been softer than the fiscal 2025 close suggested. First quarter revenue fell 4 percent, and residential same-branch sales dropped more than 11 percent. The second quarter showed consolidated revenue at a record $777.8 million, but installation revenue declined 0.7 percent. Gross margin fell 90 basis points in that quarter. Management guides to at least $100 million of acquisition revenue this year and cites heavy commercial backlog as a support. The variable set that decides the next two years of stock performance: residential starts, heavy commercial demand, acquisition pricing, and the leverage trajectory. The lower-margin Other segment gained share, and the mix cost showed up directly in profitability.
At a market capitalization near $5.6 billion, the stock prices roughly 10.8 times trailing adjusted EBITDA and a high-teens multiple on normalized earnings, a valuation that already embeds the commercial mix story working. The fair value range in this report spans the high $130s to the high $160s under bear and bull assumptions, with the base case in the high $140s, leaving limited asymmetric upside from here. The stock is a cyclical that is paying for its own re-rating, and the credit rating says the cushion is thinner than the equity story implies.